Pages that link to "Q35010521"
Jump to navigation
Jump to search
The following pages link to RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients (Q35010521):
Displaying 21 items.
- STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer (Q26998940) (← links)
- Reduced RKIP expression levels are associated with frequent non-small cell lung cancer metastasis and STAT3 phosphorylation and activation (Q33684945) (← links)
- Mucin 2 silencing promotes colon cancer metastasis through interleukin-6 signaling. (Q33918398) (← links)
- Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells (Q35732325) (← links)
- Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma (Q37267712) (← links)
- Overexpression of gelsolin reduces the proliferation and invasion of colon carcinoma cells (Q37297568) (← links)
- Glycoprotein 130 is associated with adverse postoperative clinical outcomes of patients with late-stage non-metastatic gastric cancer (Q37472258) (← links)
- Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway (Q37700932) (← links)
- RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-κB/Snail/YY1/RKIP resistance-driver loop (Q38322277) (← links)
- Understanding perspectives of signalling mechanisms regulating PEBP1 function (Q38888382) (← links)
- Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma (Q39286167) (← links)
- Oxaliplatin induces muscle loss and muscle-specific molecular changes in MICE. (Q47841514) (← links)
- Effects of thalidomide on growth and VEGF-A expression in SW480 colon cancer cells (Q49513925) (← links)
- Foxp3 expression in CD4+CD25+Foxp3+ regulatory T cells promotes development of colorectal cancer by inhibiting tumor immunity (Q51382004) (← links)
- Blocking fatty acid-fueled mROS production within macrophages alleviates acute gouty inflammation. (Q52628078) (← links)
- Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer (Q57115352) (← links)
- Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin (Q58589967) (← links)
- RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact (Q58704356) (← links)
- Oxaliplatin regulates myeloid-derived suppressor cell-mediated immunosuppression via downregulation of nuclear factor-κB signaling (Q61454563) (← links)
- Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling. (Q64890663) (← links)
- RAF Kinase Inhibitory Protein Expression and Phosphorylation Profiles in Oral Cancers (Q94363716) (← links)